Hetero Labs' Nakkapalli facility has come under scrutiny after the USFDA identified six major compliance issues, including the use of…
Biocon Ltd. actions Attend volatile movements on Tuesday, October 7, after its entirely subsidiary belonging to provisional approval of the…